Controlling the thickness of the atherosclerotic plaque by statin medication

Dorota Formanowicz1, Jacek B Krawczyk2

  • 1Department of Clinical Biochemistry and Laboratory Medicine, Poznan University of Medical Sciences, Poznan, Poland.

Plos One
|October 13, 2020
PubMed

Insights

This study introduces a novel mathematical model for atherosclerosis, identifying optimal statin treatment timing and dosage based on patient age and intima-media thickness (IMT). The model visualizes treatment viability kernels to guide clinical decisions.

Area of Science:

  • Cardiovascular Medicine
  • Mathematical Biology
  • Control Theory

Background:

  • Atherosclerosis is a complex, chronic inflammatory arterial disease influenced by multiple factors.
  • Current disease management relies on statin therapy to control plaque progression.
  • Treatment effectiveness is contingent on the patient's age and intima-media thickness (IMT) at the initiation of statin therapy.

Purpose of the Study:

  • To develop a novel control-theoretic mathematical model for estimating atherosclerosis states.
  • To identify the 'viability kernels' representing conditions under which statin therapy can effectively restrain disease progression.
  • To provide clinicians with a tool to optimize statin treatment initiation and dosage.

Main Methods:

  • Application of control-theoretic principles to model atherosclerosis dynamics.
  • Computation of viability kernels, representing sets of [age, IMT] states from which disease progression is controllable.
  • Modeling was performed for two different statin treatment doses.

Main Results:

  • Two distinct viability kernels were computed, each corresponding to a specific statin dose.
  • These kernels define the [age, IMT] ranges where statin treatment is effective in restraining atherosclerosis.
  • The study highlights that beyond these kernels, disease and age advancement limit treatment efficacy.

Conclusions:

  • The developed mathematical model offers an original approach to understanding and managing atherosclerosis.
  • Viability kernels visually represent the trade-offs between early and late statin treatment initiation.
  • The findings aid clinicians in making informed decisions regarding the optimal timing and dosage of statin therapy for atherosclerosis control.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
219
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
538
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
150
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
500
Inflammation01:38

Inflammation

Overview
60.0K